Aigen Investment Management LP Sells 1,214 Shares of The Clorox Company (NYSE:CLX)

Aigen Investment Management LP cut its holdings in The Clorox Company (NYSE:CLX) by 39.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 1,849 shares of the company’s stock after selling 1,214 shares during the quarter. Aigen Investment Management LP’s holdings in Clorox were worth $301,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Clorox by 0.3% in the first quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after acquiring an additional 48,632 shares during the last quarter. Nuance Investments LLC lifted its holdings in Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after buying an additional 960,094 shares in the last quarter. Van ECK Associates Corp boosted its position in Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Clorox by 14.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after buying an additional 120,716 shares during the period. Finally, Acadian Asset Management LLC raised its position in shares of Clorox by 26.5% during the first quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after acquiring an additional 184,847 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CLX. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $155.00.

Clorox Price Performance

Shares of NYSE CLX opened at $167.69 on Friday. The company has a fifty day moving average price of $162.39 and a 200 day moving average price of $147.34. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.09. The firm has a market cap of $20.76 billion, a PE ratio of 58.43, a PEG ratio of 3.06 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period last year, the company earned $0.49 earnings per share. Research analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 170.04%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.